Altimmune, Inc. (FRA:3G0)
Germany
· Delayed Price · Currency is EUR 4.451
+0.178 (4.17%)
At close: Dec 5, 2025
Altimmune Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 0.02 | 0.02 | 0.43 | -0.07 | 4.41 | 8.19 | Upgrade
|
| Revenue Growth (YoY) | -61.54% | -95.30% | - | - | -46.12% | 41.09% | Upgrade
|
| Cost of Revenue | 67.8 | 82.23 | 65.8 | 70.45 | 73.84 | 33.51 | Upgrade
|
| Gross Profit | -67.78 | -82.21 | -65.37 | -70.52 | -69.43 | -25.32 | Upgrade
|
| Selling, General & Admin | 22.68 | 20.97 | 18.14 | 17.13 | 15.41 | 13.21 | Upgrade
|
| Operating Expenses | 22.68 | 20.97 | 18.14 | 17.13 | 15.41 | 13.21 | Upgrade
|
| Operating Income | -90.46 | -103.17 | -83.51 | -87.65 | -84.84 | -38.53 | Upgrade
|
| Interest Expense | -0.76 | -0.01 | -0.04 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Interest & Investment Income | 6.67 | 8.07 | 7.35 | 2.87 | 0.2 | 0.32 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.05 | 0.05 | 0.17 | -0.03 | -0.37 | 0.02 | Upgrade
|
| EBT Excluding Unusual Items | -84.6 | -95.06 | -76.03 | -84.82 | -85.02 | -38.2 | Upgrade
|
| Asset Writedown | - | - | -12.42 | - | -11.37 | - | Upgrade
|
| Other Unusual Items | - | - | - | -0.09 | -0.7 | -16.27 | Upgrade
|
| Pretax Income | -84.6 | -95.06 | -88.45 | -84.91 | -97.09 | -54.46 | Upgrade
|
| Income Tax Expense | -0.68 | - | - | -0.2 | - | -5.42 | Upgrade
|
| Net Income | -83.92 | -95.06 | -88.45 | -84.71 | -97.09 | -49.04 | Upgrade
|
| Net Income to Common | -83.92 | -95.06 | -88.45 | -84.71 | -97.09 | -49.04 | Upgrade
|
| Shares Outstanding (Basic) | 79 | 71 | 53 | 47 | 41 | 26 | Upgrade
|
| Shares Outstanding (Diluted) | 79 | 71 | 53 | 47 | 41 | 26 | Upgrade
|
| Shares Change (YoY) | 17.16% | 33.35% | 13.47% | 13.67% | 61.03% | 95.33% | Upgrade
|
| EPS (Basic) | -1.06 | -1.34 | -1.66 | -1.81 | -2.35 | -1.91 | Upgrade
|
| EPS (Diluted) | -1.06 | -1.34 | -1.66 | -1.81 | -2.35 | -1.91 | Upgrade
|
| Free Cash Flow | -66.36 | -79.85 | -75.86 | -62.71 | -90.36 | -34.51 | Upgrade
|
| Free Cash Flow Per Share | -0.83 | -1.13 | -1.43 | -1.34 | -2.19 | -1.35 | Upgrade
|
| Operating Margin | -452310.00% | -515860.00% | -19603.29% | - | -1923.90% | -470.78% | Upgrade
|
| Profit Margin | -419575.00% | -475295.00% | -20762.21% | - | -2201.59% | -599.20% | Upgrade
|
| Free Cash Flow Margin | -331810.00% | -399240.00% | -17806.81% | - | -2048.87% | -421.62% | Upgrade
|
| EBITDA | -90.34 | -102.93 | -83.03 | -87.16 | -84.29 | -38.1 | Upgrade
|
| D&A For EBITDA | 0.12 | 0.24 | 0.48 | 0.49 | 0.55 | 0.43 | Upgrade
|
| EBIT | -90.46 | -103.17 | -83.51 | -87.65 | -84.84 | -38.53 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.